Navigation Links
SemBioSys announces second quarter 2008 financial and operational results
Date:8/5/2008

2008 2007

------------ ------------ ------------ ------------

$ $ $ $

Cash provided by

(used in)

Operating activities

Net loss for the

period (6,414,856) (3,225,371) (11,431,911) (6,453,782)

Add items not

affecting cash:

Amortization 580,733 241,887 1,074,567 469,945

Loss on sale of

property and

equipment - 1,483 - 1,483

Stock-based

compensation 175,947 186,654 355,850 365,704

Unrealized foreign

exchange loss (gain) 4,991 (128,534) 49,002 (149,544)

Non-cash interest

expense 18,288 - 37,068 -

------------ ------------ ------------ ------------

(5,634,897) (2,923,881) (9,915,424) (5,766,194)

------------ ------------ ------------ ------------

------------ ------------ ------------ ------------

Change in non-cash

working capital and

other balances

related to

operations 88,886 (686,470) 298,802 795,297

------------ ------------ ------------ ------------

Cash used in operating

activities (5,546,011) (3,610,351) (9,616,622) (4,970,897)

------------ ------------ ------------ ------------

------------ ------------ ------------ ------------

Financing activities

Issuance of capital

stock - - - 15,904,488

Share issue costs - (168,939) (57,884) (1,525,478)

Issuance of

convertible
'/>"/>

SOURCE SemBioSys Genetics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. SemBioSys submits IND for safflower-produced insulin to U.S. FDA
2. SemBioSys Demonstrates Functionality of its Safflower Produced Apo AI(Milano)
3. SemBioSys to present at the Needham & Company Biotechnology and Medical Technology Conference
4. SemBioSys provides update on shrimp feed additive, Immunosphere(TM)
5. SemBioSys announces first quarter 2008 financial and operational results
6. SemBioSys receives milestone payments from AVAC Ltd.
7. SemBioSys initiates toxicology study for safflower-produced insulin
8. SemBioSys announces 2007 financial and operational results
9. SemBioSys GLA Partner Enters Strategic Alliance for the Sales and Marketing of GLA-Rich Safflower Oil
10. SemBioSys awarded key patent for the production of oleosome emulsions by the European Patent Office
11. SemBioSys to present at the 10th Annual BIO CEO & Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... Nev. , July 28, 2015  PDL BioPharma, ... today announced that the Company will release its second ... 30, 2015, on Wednesday, August 5, 2015, after market ... webcast that day at 4:30 p.m. Eastern Time to ... the call will be available via the webcast link ...
(Date:7/28/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/z54c4k/biomedical ... "Biomedical Refrigerators and Freezers Market - Global Industry ... - 2022" report to their offering. ... market has been segmented based on applications: hospitals, ... others. The others segment includes applications of biomedical ...
(Date:7/28/2015)... July 28, 2015  Moerae Matrix Inc. announced ... clinical trial with MMI-0100, a first-in-class inhibitor of ... for pulmonary disorders characterized by inflammation and fibrosis.  ... Kingdom , is a double-blind, two-way cross-over ... safety and tolerability of MMI-0100 when given via ...
(Date:7/28/2015)... , July 28, 2015 ... company utilizing its proprietary plant-based rhCollagen technology for ... has been appointed Senior Director of Business Development, ... http://photos.prnewswire.com/prnh/20150728/246955 ) , Ms. ... marketing, regulatory and business strategy. Prior to joining ...
Breaking Biology Technology:PDL BioPharma to Announce Second Quarter 2015 Financial Results on August 5, 2015 2Biomedical Refrigerators and Freezers Market Report - Global Industry Analysis 2015 2Biomedical Refrigerators and Freezers Market Report - Global Industry Analysis 2015 3Moerae Initiates Lipopolysaccharide (LPS) Challenge Study of Inhaled MMI-0100 for Pulmonary Disease Following Encouraging Safety and Tolerability Observed in Single Ascending Dose Phase 1 Study 2CollPlant Names Shomrat Shurtz Senior Director of Business Development 2
... NEW YORK, Sept. 8 Reportlinker.com announces that ... , , Small Molecule Kinase ... http://www.reportlinker.com/p0131227/Small-Molecule-Kinase-Inhibitors.html , , ... Inhibitors in Millions of US$ by the following Product Segments: ...
... , , , Dan ... PHILADELPHIA, Sept. 8 PriceSpective, a value strategy consultancy that ... pleased to announce that it has hired Dan Ross to open ... brings 9 years of experience working with healthcare companies in both ...
... , , ... (Nasdaq: PPHM ) today reported completion of patient enrollment ... and paclitaxel in advanced breast cancer patients. The trial,s planned ... undergoing treatment and follow-up. The primary objective of the multi-center, ...
Cached Biology Technology:Reportlinker Adds Small Molecule Kinase Inhibitors Report 2Reportlinker Adds Small Molecule Kinase Inhibitors Report 3Reportlinker Adds Small Molecule Kinase Inhibitors Report 4Reportlinker Adds Small Molecule Kinase Inhibitors Report 5Reportlinker Adds Small Molecule Kinase Inhibitors Report 6Reportlinker Adds Small Molecule Kinase Inhibitors Report 7Reportlinker Adds Small Molecule Kinase Inhibitors Report 8Reportlinker Adds Small Molecule Kinase Inhibitors Report 9Reportlinker Adds Small Molecule Kinase Inhibitors Report 10PriceSpective Continues Global Expansion With New San Diego Office 2Peregrine Pharmaceuticals Reports Advances in Bavituximab Clinical Program 2Peregrine Pharmaceuticals Reports Advances in Bavituximab Clinical Program 3Peregrine Pharmaceuticals Reports Advances in Bavituximab Clinical Program 4Peregrine Pharmaceuticals Reports Advances in Bavituximab Clinical Program 5
(Date:7/21/2015)...  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... on the growing mobile commerce market and creator ... has filed provisional patent 62/192218 for ... This invention highlights next generation payment technology from ... also the user using unique personal identifiers including ...
(Date:7/13/2015)... , Jul. 13, 2015 NXT-ID, Inc. ... a biometric authentication company focused on the growing ... filed provisional patent 62/188684 for BEHAVIORAL-DIRECTED ... another new convenient and secure method to make ... innovative payment methods, introduced with its groundbreaking voice-direct ...
(Date:7/9/2015)... , July 9, 2015  Synaptics ... developer of human interface solutions, today announced ... industry,s first fully hardware encapsulated fingerprint sensor ... authentication technology is literally off the grid, ... biometric matching within the fingerprint sensor to ...
Breaking Biology News(10 mins):NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3
... The world,s most powerful neutron source should be built in ... At a meeting in Brussels last night (28 May), ... the European Spallation Source (ESS), with a further two voting ... be the world,s most advanced centre for materials research, enabling ...
... say they,ve made a big improvement in a new breed ... one that may be a valuable addition to the battle ... antibody attached to a nanowire that,s attached to an electrical ... binds to is present in the liquid, it will bind ...
... Animals can simplify the brain control of their limb ... that operates against a spring made of the almost ... and illustrated by striking photographs and high-speed video footage, ... , of the movements of the mouthparts of crabs ...
Cached Biology News:Sweden to host 1.3 billion Euro research center 2A quicker, cheaper SARS virus detector -- one easily customizable for other targets 2Resilin springs simplify the control of crustacean limb movements 2
1, 2 or 8 PreMixes are included as part of the FailSafe™ PCR System....
1, 2 or 8 PreMixes are included as part of the FailSafe™ PCR System....
Request Info...
... catalyzes the degradation of single-stranded DNA and ... While the nuclease prefers ssDNA over dsDNA ... enzyme degrades double-stranded DNA from both ends ... for transcript mapping studies (3,4), for flushing ...
Biology Products: